A Phase II, Multicenter, Open-Label Study to Evaluate the Safety and Efficacy of SKB500 Combinations in Patients With Small Cell Lung Cancer
NCT07296809 · RECRUITING · Phase 2
We track 1 ClinicalTrials.gov studies led by Sichuan Kelun Biotech Biopharmaceutical Co Ltd. The portfolio skews toward Phase 2 (1 trials).
1 clinical trials sponsored by Sichuan Kelun Biotech Biopharmaceutical Co Ltd.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 2 | 1 | 100% |
Sichuan Kelun Biotech Biopharmaceutical Co Ltd currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 2.
Sichuan Kelun Biotech Biopharmaceutical Co Ltd conducts research across multiple therapeutic areas. Browse the trial listings for details.
Yes, Sichuan Kelun Biotech Biopharmaceutical Co Ltd currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.